APA (7th ed.) Citation

Wu, X., Wu, Q., Ding, Q., Zhuang, Y., Luo, L., Zhang, Y., . . . Liu, Y. (2025). A phase I study to evaluate the safety, tolerability, and pharmacokinetics of HEC113995PA·H2O, a novel dual-acting serotonergic antidepressant, in healthy subjects. Frontiers in pharmacology, 16, 1500974. https://doi.org/10.3389/fphar.2025.1500974

Chicago Style (17th ed.) Citation

Wu, Xue, et al. "A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HEC113995PA·H2O, a Novel Dual-acting Serotonergic Antidepressant, in Healthy Subjects." Frontiers in Pharmacology 16 (2025): 1500974. https://doi.org/10.3389/fphar.2025.1500974.

MLA (9th ed.) Citation

Wu, Xue, et al. "A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HEC113995PA·H2O, a Novel Dual-acting Serotonergic Antidepressant, in Healthy Subjects." Frontiers in Pharmacology, vol. 16, 2025, p. 1500974, https://doi.org/10.3389/fphar.2025.1500974.